The Center for AIDS Prevention Studies (CAPS) is a highly productive, vibrant, and innovative organization, conducting cutting edge and high-impact HIV prevention research, with a cutting-edge and multidisciplinary faculty, and strong and stable institutional support from one of the highest ranked medical schools in the country. CAPS' important contributions to HIV prevention science are evident in the over 470 manuscripts published during the current funding period. In a tight funding environment, CAPS has continued to successfully obtain NIH research grants, with a 60% success rate, and successfully diversified its funding portfolio to include projects examining the effective implementation of HIV prevention science. The Center will build on its long and successful history of providing critical support to its cadre of world-class scientists who have pushed scientific boundaries in addressing the HIV pandemic. CAPS' research is distinguished by its depth and breadth, enabling the center to conduct the studies necessary to reach global indicators for ending the epidemic. CAPS' mission is actualized via an infrastructure designed to ignite scientific innovation and high impact research. The cores proposed in this renewal application were designed to ensure CAPS remains at the forefront of driving progress in HIV prevention research.
The specific aims are to: 1. Catalyze a scientific environment that ignites timely, innovative, high impact, interdisciplinary research that nimbly addresses current and emerging issues in the HIV epidemic; 2. Build the number, effectiveness, and diversity of investigators and community and public health partners who are trained to conduct high-impact HIV research; 3. Develop and promote the use of innovative strategies for collection, management, and analysis of complex data to advance HIV prevention science in order to optimize the development and implementation of efficacious and effective HIV preventive interventions, and promote the use of cutting edge technologies; 4. Develop and maximize the public health impact of optimally efficacious, culturally competent and implementable interventions, strategies and prevention tools by moving them into policy and practice. CAPS will continue to push the limits of innovative and interdisciplinary HIV prevention research, adding value to the fight to end the HIV epidemic through a solid basic social and behavioral science foundation, innovative and efficacious interventions, and robust research in implementation science, including explication of significant HIV/AIDS policy questions.

Public Health Relevance

Since its inception, the Center for AIDS Prevention Studies (CAPS) has been at the forefront of conducting theory-driven, rigorous research to prevent new HIV infections, improve health outcomes among those infected and reduce significant HIV-related health disparities. The Center will build on its long and successful history of providing critical support to its cadre of world-class scientists that conduct interdisciplinary research to achieve an end to the HIV epidemic. .

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062246-17
Application #
9334291
Study Section
Special Emphasis Panel (ZMH1)
Program Officer
Gordon, Christopher M
Project Start
2001-09-24
Project End
2021-08-31
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
17
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Wood, Troy J; Koester, Kimberly A; Christopoulos, Katerina A et al. (2018) If someone cares about you, you are more apt to come around: improving HIV care engagement by strengthening the patient-provider relationship. Patient Prefer Adherence 12:919-927
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Hughes, Shana D; Custer, Brian; Laborde, Nicole et al. (2018) Transition to a 1-year deferral for male blood donors who report sexual contact with men: staff perspectives at one blood collection organization. Transfusion 58:1909-1915
Truong, Hong-Ha M; Fatch, Robin; Do, Tri D et al. (2018) Hepatitis B Vaccination and Infection Prevalence Among Men Who Have Sex With Men Who Travel Internationally. Sex Transm Dis 45:e25-e28
Truong, Hong-Ha M; Fatch, Robin; Tan, Judy Y et al. (2018) Whose Responsibility Is It? Beliefs About Preventing HIV Transmission Among Men Who Have Sex With Men. Sex Transm Dis 45:e43-e48
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Lee, Jonathan S; Nápoles, Anna; Mutha, Sunita et al. (2018) Hospital discharge preparedness for patients with limited English proficiency: A mixed methods study of bedside interpreter-phones. Patient Educ Couns 101:25-32
Rice, Whitney S; Logie, Carmen H; Napoles, Tessa M et al. (2018) Perceptions of intersectional stigma among diverse women living with HIV in the United States. Soc Sci Med 208:9-17
Chamie, Gabriel; Kato-Maeda, Midori; Emperador, Devy M et al. (2018) Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda. PLoS One 13:e0192666
Lippman, Sheri A; Lane, Tim; Rabede, Oscar et al. (2018) High Acceptability and Increased HIV-Testing Frequency After Introduction of HIV Self-Testing and Network Distribution Among South African MSM. J Acquir Immune Defic Syndr 77:279-287

Showing the most recent 10 out of 682 publications